Tris Pharma unveiled its new drug delivery platform, NoBuse, which enables companies to deliver effective pain relief or ADHD products.
The NoBuse delivery system is engineered to prevent abuse on a physical level without the need for additional ingredients. NoBuse employs a technique where the drug is complexed to very fine polymeric particles and coated with a highly-flexible, non-breakable film resulting in particles that are difficult to extract drug from, even after crushing the tablet or dissolving it in alcohol.
The technology works across a range of oral dosage forms including tablets, liquid suspensions, orally-disintegrating tablets, and drug strips. It can also be used to formulate an immediate-release product with a built-in abuse deterrent.
Published in Drug Discovery & Development magazine: Vol. 12, No. 1, January, 2009, p.11.
Filed Under: Drug Discovery
